This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...

CORPUS CHRISTI, Texas — When you head to the doctor's office, some of our local clinics now have a special test that can tell if you have a viral or bacterial infection in just 15 minutes. Physician's ...

The company behind America’s first biometric “smart gun” — one that fires only when gripped by authorized users — will face a crucial test in the coming weeks. After decades of failed attempts by ...

BioFire Diagnostics may have agreed to sell itself to French diagnostics giant bioMérieux for $450 million, but the company plans to keep its name and senior management and continue growing at its ...

ALBUQUERQUE, NM / ACCESSWIRE / August 8, 2022 / Net Medical (OTC Pink:NMXS) announced today it has begun offering biomerieux's new BIOFIRE® Joint Infection (JI) panel to support orthopedic surgeons in ...

BioFire Diagnostics won 510(k) clearance for its gastrointestinal panel for infectious diarrhea, following in the footsteps of the company's acquisition by French diagnostic giant bioMérieux.

SALT LAKE CITY--(BUSINESS WIRE)--BioFire Diagnostics, Inc. today announced that it has submitted the FilmArray Blood Culture Identification (BCID) Panel to the U.S. Food and Drug Administration (FDA) ...

bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, today announced that its subsidiary, BioFire Defense, has received Emergency Use Authorization by the U.S. Food and Drug ...

The U.S. Army Medical Materiel Development Activity’s Warfighter Protection and Acute Care Project Management Office, along with its commercial partner BioFire Defense, announced the U.S. Food and ...

SALT LAKE CITY--(BUSINESS WIRE)--BioFire Diagnostics, Inc., today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 8,394,608 covering the company’s FilmArray ...